Newsletter

www.PennyStockAlerts.com does its best to bring you accurate information but errors may and sometimes do occur. Always do your own research before trading. PennyStockAlerts.com is not a licensed financial advisor.  This is a paid advertisement, not a solicitation or recommendation to buy or sell securities.

Today AXXE didn't explode...yet.  It made a quick upward move and again traded down and then sideways, closing down 5%.

Normally I only stick with a play for a single day, but there are rare special cases where I make an exception.  I think AXXE absolutely DOES have the potential to deliver a strong possible rally.

AXXE has flown on news in the past, and this company has one of the most incredibly strong and consistent pipelines of news I've seen in an OTC stock.  I want to keep an eye on it, any developments could create an exciting trading situation.

Remember how well AXXE has traded in the past, it is almost ALWAYS a winner for us.  While its past performance of course does not predict its future performance, AXXE has been very powerful coming off similar situations in the recent past.

Could AXXE just be "winding up"?

Keep your eyes on AXXE, this Proven Hero is STILL on high alert.  Don't get burned if we see no momentum, but IF we do see a strong surge...AXXE may be primed to deliver massive potential profits.

Watch AXXE in the near-term future, this play could get interesting in a hurry!

Read my full AXXE alert again below:

My Red Hot Proven Winner is AXXE - Axxess Pharma 

About Axxess Pharma Inc.:

About Axxess Pharma Inc.: Axxess Pharma Inc. is a Nevada Corporation operating through its wholly owned Canadian Subsidiary: Axxess Pharma Canada Inc., headquartered in Toronto. Axxess is a specialty Health Care Products Company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas. Axxess's goal is to bring additional products to the market and provide new, innovative options for better health spanning areas such as high cholesterol, blood pressure, acute pain -- to optimal health management through improved nutritional supplements. To learn more about our new products TapouT Extreme Muscle Growth and TapouT Muscle Recovery, please visit: http://buytapoutme.com and http://www.tapoutmusclerecovery.com.

For more information, please visit www.axxesspharmainc.com, or contact Investor Relations at (973) 351-3868.

AXXE is a health care company dedicated to improving health and quality of life by offering select medicines, nutritional supplements and over the counter remedies all across the Americas.

AXXE just came out with MASSIVE news, you've got to take a look at this:

http://finance.yahoo.com/news/axxess-pharma-inc-launch-large-120000283.html

It says that AXXE, a specialty pharmaceutical and nutritional supplements company, through its wholly owned subsidiary, AllStar Health Brands Inc., is pleased to announce they have signed a large scale marketing agreement with Inside Fitness Magazine -- Canada's number #1 fitness magazine.

The aggressive marketing campaign will include full-page ads, distributed throughout Canada. The ads will market Axxess Pharma's line of TapouT-branded topical pain relief, muscle growth and recovery supplements.

Inside Fitness Magazine is one of Canada's fastest growing publishing companies covering the latest trends in health, sports, strength & conditioning, fitness, nutrition and more. Inside Fitness Magazine is a collaboration of the brightest and most knowledgeable fitness, health and bodybuilding experts in the industry; including the likes of Jonathan Chaimberg, Tommy Europe, Stephanie Joanne and Brent Bishop.

With a distinct Canadian flare, the magazine caters to readers all over the world including the United States, England, Germany, Austria, Australia, Brazil, Greece, Grand Cayman, Spain, Thailand, Singapore, Italy and New Zealand.

Daniel Bagi, President of Axxess, stated, "We are excited to be featured on the cover of an upcoming issue of Inside Fitness Magazine. The magazine has a massive distribution and subscribership, all focused on health and fitness." Daniel Bagi further stated, "Next month we will also promote our products in the Inside Fitness Magazine (IMF) Booth at the Toronto Pro Super Show. Our aggressive advertising and marketing effort through IMF is anticipated to continue accelerating Axxess Pharma's sales."

Wow!  That could mean incredible NEW exposure for the company, which could drive buying and create major trading gain potential.

The pain management industry is an EXTREMELY powerful backdrop for a microcap growth story, and AXXE is telling a story that is sure to electrify investors...and potentially create VERY profitable "spikes" for traders to capitalize on.

http://finance.yahoo.com/q/h?s=AXXE+Headlines

I'll break down the incredibly exciting AXXE/TapouT story in a nutshell for you right here, so you can see how this story is a one in a million situation I had to put in front of you today.

Read about TapouT here:

About TapouT: TapouT is a lifestyle brand that has been at the forefront of Mixed Martial Arts since its inception in 1997. The label is rapidly growing into other sports and categories, offering merchandise for men, women and kids. TapouT has endorsed high-profile professional athletes who compete in sports such as basketball, football, baseball, stock car racing, and most famously, MMA. TapouT is sold in sporting goods stores, specialty retailers and online. For updates and more information, please visit TapouT.com.

https://www.facebook.com/TapouT
https://twitter.com/TapouT
http://www.youtube.com/tapout

AXXE has a Worldwide Exclusive Agreement with TapouT.

TapouT is a World Leading Athletic Lifestyle Brand, with revenue of $350 million.

TapouT is owned by "Authentic Brands Group."  Authentic Brands Group is a MAJOR Company! 

Wikipedia states "ABG owns such popular consumer brands as Juicy Couture, Elvis Presley, Muhammad Ali, Marilyn Monroe, Prince Tennis, TapouT, Hickey Freeman, Judith Leiber and several others. Its brands are available in such stores as Kohl's, Kmart, Sears, Macy's, Bergdorf Goodman, Neiman Marcus, Bloomingdales, JC Penney and Walmart."

You wouldn't think the man who runs a Mega-Corporation like ABG would have anything to do with a tiny OTC Company.  Especially a super tiny one, like AXXE with a total market valuation of under $15 million.  The truth is the OTC market is plagued with frauds, plenty of Wolves of Wall Street, and just a general negative image...which is mostly well-deserved.  You could probably count on one hand the number of times a guy who runs an enormously powerful Corporate Empire goes on the record to praise a microcap company's product, as well as praising his partnership with them.

Yet this nearly unheard of  event happened for AXXE!

Nick Woodhouse, President for TapouT/Authentic Brands Group stated, "We are very excited about this partnership with Axxess Pharma, Inc. We feel that Axxess incredible pain relief formulas are going to be well received by TapouT customers across North America. As the TapouT brand continues to grow, Axxess will have an opportunity to grow with us."

Nick Woodhouse is the 2nd person named on the Wikipedia entry about Authentic Brands Group, only behind the Founder and CEO himself!  The guy who is the #2 head honcho at the Company who OWNS TapouT, is making positive comments, "ON THE RECORD"...about AXXE!

That's as strong a testament to the credibility of this Company as I've ever seen for any OTC company that gets promoted in newsletters.

You can look up the Wikipedia entry here: http://en.wikipedia.org/wiki/Authentic_Brands_Group

Looks good, but still have to throw in the warning because you never know what could happen.

*** Be sure to trade with caution and to verify all information for yourself before trading.  Do your own research and consult with a licensed professional before trading any alert.  You may easily lose your entire investment.  In my personal opinion, the vast majority of companies alerted in this newsletter are too risky for traditional investment, and are discussed here purely from a short-term/daytrading perspective.  All traders should have substantial experience before engaging in the exceptionally risky process that is trading small, micro and nano-cap equities. ***

Just days ago AXXE put out this monster of a PR:

http://finance.yahoo.com/news/axxess-pharma-pleased-announce-amazon-120000959.html

It says AXXE's TapouT pain relief line has SOLD OUT ON AMAZON!!

That's huge, and is propelling the momentum that AXXE has a habit of generating.

And yet...AXXE is EXTREMELY cheap at just .31!

The last time that AXXE broke out for us, it was at .29...virtually the same exact price that worked so well for us last time!!

Look at this chart:

So far this year AXXE has gone from .15 to .50 on HUGE volume for a 233% gain. 

It has been consolidating and looks poised to breakout for ANOTHER monster rally!

All eyes on AXXE for a potential breakout...

PSA - Stock Psycho

www.pennystockalerts.com

Don’t ever invest based on the info or statements of this newsletter.  Do your own research and consult with a licensed professional before investing, only invest what you are prepared to lose. Any statements and opinions given are amateur and biased and should be treated as such. Past performance does not indicate future performance in any way. The performance of all alerts uncompensated and compensated in no way predict the performance of current and/or upcoming alerts. Check the latest SEC filings before investing, and research other information on the risks of investing in microcap companies at www.sec.gov

 

READ IMPORTANT DISCLAIMER

Disclaimer – This newsletter is a paid advertisement, not a recommendation nor an offer to buy or sell securities. This newsletter is owned, operated and edited by Focus Media.  Any reference to “we” or “our” refers to Focus Media.  Our business model is to be financially compensated to market and promote small public companies.  By reading our newsletter and our website you agree to the terms of our disclaimer, which are subject to change at any time. We are not registered or licensed in any jurisdiction whatsoever to provide investing advice or anything of an advisory or consultancy nature, and are therefore unqualified to give investment recommendations. Always do your own research and consult with an licensed investment professional before investing. This communication is never to be used as the basis of making investment decisions, and is for entertainment purposes only. At most, this communication should serve only as a starting point to do your own research and consult with a licensed professional regarding the companies profiled and discussed. Companies with low price per share are speculative and carry a high degree of risk, so only invest what you can afford to lose. By using our service you agree not to hold our site, its editor’s, owners, or staff liable for any damages, financial or otherwise, that may occur due to any action you may take based on the information contained within our newsletters or on our website.
 
 
We do not advise any reader take any specific action. Losses can be larger than expected if the company experiences any problems with liquidity or wide spreads. Our website and newsletter are for entertainment purposes only. Never invest purely based on our alerts. Gains mentioned in our newsletter and on our website may be based on EOD or intraday data. This publication and their owners and affiliates may hold positions in the securities mentioned in our alerts, which we may sell at any time without notice to our subscribers, which may have a negative impact on share prices.
 

We have been compensated forty two thousand dollars cash via bank wire for the currently active AXXE investor relations marketing campaign, by a third party, Ramos and Ramos.  We have been compensated in the past twenty five thousand dollars cash via bank wire by a third party, Ramos and Ramos, to conduct investor relations advertising and marketing campaign for AXXE, which has now expired. We have also been compensated fifty thousand dollars cash via bank wire for a previous AXXE advertising campaign by a different third party, Ramm Venture Development, which is also expired, but all compensation expired or current or expired should still be considered as a cause of bias. In total, we have been compensated one hundred and seventeen thousand for AXXE promotional marketing.  Focus Media’s business model is to receive financial compensation to promote public companies.  This compensation is a major conflict of interest in our ability to be unbiased regarding AXXE. Therefore, this communication should be viewed as a commercial advertisement only.  We have not investigated the background of the hiring third party or parties. The third party, profiled company, or their affiliates likely wish to liquidate shares of the profiled company at or near the time you receive this communication, which has the potential to hurt share prices. Any non-compensated alerts are purely for the purpose of expanding our database for the benefit of our future financially compensated investor relations efforts. Frequently companies profiled in our alerts may experience a large increase in volume and share price during the course of investor relations marketing, which may end as soon as the investor relations marketing ceases. The investor relations marketing may be as brief as one day, after which a large decrease in volume and share price is likely to occur. Our emails may contain forword looking statements, which are not guaranteed to materialize due to a variety of factors.


We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. The information is collected from public sources, such as the profiled company’s website and press releases, but is not researched or verified in any way whatsoever to ensure the publicly available information is correct. Furthermore, Focus Media often employs independent contractor writers who may make errors when researching information and preparing these communications regarding profiled companies. Independent writers’ works are double-checked and verified before publication, but it is certainly possible for errors or omissions to take place during editing of independent contractor writer’s communications regarding the profiled company(s). You should assume all information in all of our communications is incorrect until you personally verify the information, and again are encouraged to never invest based on the information contained in our written communications. The information in our disclaimers is subject to change at any time without notice. See full disclaimer at www.pennystockalerts.com/disclaimer